Euclidean Capital

Latest statistics and disclosures from Euclidean Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are SPY, INDA, VEU, FHTX, ORIC, and represent 98.02% of Euclidean Capital's stock portfolio.
  • Added to shares of these 2 stocks: SPY (+$32M), VEU (+$32M).
  • Started 1 new stock position in VEU.
  • Euclidean Capital was a net buyer of stock by $64M.
  • Euclidean Capital has $907M in assets under management (AUM), dropping by 13.94%.
  • Central Index Key (CIK): 0001825034

Tip: Access up to 7 years of quarterly data

Positions held by Euclidean Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Euclidean Capital

Euclidean Capital holds 12 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf Tr Tr Unit (SPY) 76.1 $690M +4% 1.2M 573.76
 View chart
Ishares Tr Msci India Etf (INDA) 15.7 $142M 2.4M 58.53
 View chart
Vanguard Intl Equity Index F Allwrld Ex Us (VEU) 3.5 $32M NEW 508k 63.00
 View chart
Foghorn Therapeutics (FHTX) 1.6 $15M 1.6M 9.31
 View chart
Oric Pharmaceuticals (ORIC) 1.1 $10M 989k 10.25
 View chart
Alector (ALEC) 0.7 $6.1M 1.3M 4.66
 View chart
Pmv Pharmaceuticals (PMVP) 0.4 $3.9M 2.6M 1.49
 View chart
23andme Holding Class A Com (ME) 0.4 $3.6M 10M 0.35
 View chart
Tenaya Therapeutics (TNYA) 0.2 $2.0M 1.0M 1.93
 View chart
Rapt Therapeutics (RAPT) 0.1 $1.3M 658k 2.01
 View chart
Surrozen Com New (SRZN) 0.1 $1.1M 88k 11.98
 View chart
Surrozen *w Exp 08/01/203 (SRZNW) 0.0 $1.8k 171k 0.01
 View chart

Past Filings by Euclidean Capital

SEC 13F filings are viewable for Euclidean Capital going back to 2020

View all past filings